Hjermstad S J, Peters K L, Briggs S D, Glazer R I, Smithgall T E
Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha 68198-6805.
Oncogene. 1993 Aug;8(8):2283-92.
The c-fes proto-oncogene product is expressed predominantly in hematopoietic cells of the myeloid lineage and has been implicated in the regulation of myeloid differentiation. The c-fes locus encodes a 93-kDa protein tyrosine kinase (p93c-fes) that possesses several structural features characteristic of the cytoplasmic class of protein tyrosine kinases, including a consensus sequence for autophosphorylation surrounding Tyr-713 and a src homology 2 (SH2) domain. To assess the effect of each of these potential regulatory sites on p93c-fes protein tyrosine kinase activity, we specifically deleted the c-fes SH2 domain using the polymerase chain reaction and replaced Tyr-713 with phenylalanine by oligonucleotide-directed mutagenesis (Y713F mutant). The resulting mutants were expressed in Escherichia coli and assayed for changes in protein tyrosine kinase activity using an immune complex kinase assay. Both mutations produced a marked decrease in the rate and extent of autophosphorylation and phosphorylation of the model substrate, enolase. To test whether the c-fes SH2 domain could interact with the autophosphorylated kinase domain, the SH2 domain was expressed as a fusion protein with glutathione S-transferase and immobilized on glutathione-agarose. The recombinant c-fes SH2 domain precipitated p93c-fes as readily as a monoclonal antibody. Binding of the SH2 domain to p93c-fes was completely dependent upon autophosphorylation, as a kinase-defective mutant of p93c-fes was not precipitated by the SH2 domain. High-affinity binding was also observed with recombinant SH2 domains from v-src and v-fps, raising the possibility of protein-protein interactions between various members of the cytoplasmic PTK family. These results indicate that the c-fes SH2 domain and consensus autophosphorylation site (Tyr-713) play major roles in the positive regulation of p93c-fes tyrosine kinase activity, possibly through intramolecular interaction.
c-fes原癌基因产物主要在髓系造血细胞中表达,并与髓系分化的调控有关。c-fes基因座编码一种93 kDa的蛋白酪氨酸激酶(p93c-fes),它具有细胞质类蛋白酪氨酸激酶的几个结构特征,包括围绕Tyr-713的自磷酸化共有序列和一个src同源2(SH2)结构域。为了评估这些潜在调控位点中的每一个对p93c-fes蛋白酪氨酸激酶活性的影响,我们使用聚合酶链反应特异性删除了c-fes SH2结构域,并通过寡核苷酸定向诱变将Tyr-713替换为苯丙氨酸(Y713F突变体)。将所得突变体在大肠杆菌中表达,并使用免疫复合物激酶测定法检测蛋白酪氨酸激酶活性的变化。两种突变均导致自磷酸化速率和程度以及模型底物烯醇化酶的磷酸化显著降低。为了测试c-fes SH2结构域是否能与自磷酸化的激酶结构域相互作用,将SH2结构域表达为与谷胱甘肽S-转移酶的融合蛋白,并固定在谷胱甘肽琼脂糖上。重组c-fes SH2结构域沉淀p93c-fes的能力与单克隆抗体一样强。SH2结构域与p93c-fes的结合完全依赖于自磷酸化,因为p93c-fes的激酶缺陷突变体不会被SH2结构域沉淀。还观察到来自v-src和v-fps的重组SH2结构域具有高亲和力结合,这增加了细胞质PTK家族各成员之间蛋白质-蛋白质相互作用的可能性。这些结果表明,c-fes SH2结构域和共有自磷酸化位点(Tyr-713)可能通过分子内相互作用在p93c-fes酪氨酸激酶活性的正向调节中起主要作用。